EIF4E2 and nonpapillary renal cell carcinoma: In ccRCC, we observed CNV gain for EIF4E1B, LARP1, GEMIN5, and DCP2, while EIF4E2 and EIF4G3 mainly had a frequency of CNV deletion (Figure 1D).